Search

Christopher S. Mccarthy

Examiner (ID: 18609, Phone: (571)272-3651 , Office: P/2113 )

Most Active Art Unit
2113
Art Unit(s)
2184, 2113
Total Applications
1245
Issued Applications
1059
Pending Applications
61
Abandoned Applications
143

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4688971 [patent_doc_number] => 20080033152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Three-Phase Partitioning Method for Purifying a Protein' [patent_app_type] => utility [patent_app_number] => 11/832830 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4516 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20080033152.pdf [firstpage_image] =>[orig_patent_app_number] => 11832830 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/832830
Three-phase partitioning method for purifying a protein Aug 1, 2007 Issued
Array ( [id] => 5120577 [patent_doc_number] => 20070142292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'COMPOSITION OF LACTOFERRIN RELATED PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/677796 [patent_app_country] => US [patent_app_date] => 2007-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 43570 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142292.pdf [firstpage_image] =>[orig_patent_app_number] => 11677796 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/677796
Composition of lactoferrin related peptides and uses thereof Feb 21, 2007 Issued
Array ( [id] => 4938832 [patent_doc_number] => 20080076151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Compositions for controlling hair growth' [patent_app_type] => utility [patent_app_number] => 11/709074 [patent_app_country] => US [patent_app_date] => 2007-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 28853 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076151.pdf [firstpage_image] =>[orig_patent_app_number] => 11709074 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/709074
Compositions for controlling hair growth Feb 20, 2007 Issued
Array ( [id] => 5242237 [patent_doc_number] => 20070020732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Mast cell-specific signal transducer and cDNA thereof' [patent_app_type] => utility [patent_app_number] => 11/529217 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3437 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020732.pdf [firstpage_image] =>[orig_patent_app_number] => 11529217 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/529217
Mast cell-specific signal transducer and cDNA thereof Sep 28, 2006 Issued
Array ( [id] => 5241759 [patent_doc_number] => 20070020251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Paralytic peptide for use in neuromuscular therapy' [patent_app_type] => utility [patent_app_number] => 11/507128 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11655 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020251.pdf [firstpage_image] =>[orig_patent_app_number] => 11507128 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/507128
Paralytic peptide for use in neuromuscular therapy Aug 20, 2006 Issued
Array ( [id] => 5834671 [patent_doc_number] => 20060246502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Rabconnectin-3-binding protein' [patent_app_type] => utility [patent_app_number] => 11/483356 [patent_app_country] => US [patent_app_date] => 2006-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16205 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246502.pdf [firstpage_image] =>[orig_patent_app_number] => 11483356 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/483356
Rabconnectin-3-binding protein Jul 6, 2006 Issued
Array ( [id] => 5732383 [patent_doc_number] => 20060257500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'TRPC6 involved in glomerulonephritis' [patent_app_type] => utility [patent_app_number] => 11/417113 [patent_app_country] => US [patent_app_date] => 2006-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 8341 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11417113 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/417113
TRPC6 involved in glomerulonephritis May 3, 2006 Abandoned
Array ( [id] => 5678538 [patent_doc_number] => 20060183894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors' [patent_app_type] => utility [patent_app_number] => 11/410777 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 7142 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183894.pdf [firstpage_image] =>[orig_patent_app_number] => 11410777 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/410777
Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors Apr 24, 2006 Abandoned
Array ( [id] => 5596209 [patent_doc_number] => 20060160126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => '90 human secreted proteins' [patent_app_type] => utility [patent_app_number] => 11/375414 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 197317 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160126.pdf [firstpage_image] =>[orig_patent_app_number] => 11375414 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/375414
90 human secreted proteins Mar 14, 2006 Abandoned
Array ( [id] => 5694971 [patent_doc_number] => 20060155118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Affinity purification system using troponin molecules as affinity ligands' [patent_app_type] => utility [patent_app_number] => 11/369285 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18336 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20060155118.pdf [firstpage_image] =>[orig_patent_app_number] => 11369285 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/369285
Affinity purification system using troponin molecules as affinity ligands Mar 5, 2006 Abandoned
Array ( [id] => 466945 [patent_doc_number] => 07235385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Methods for enhancing expression of recombinant proteins' [patent_app_type] => utility [patent_app_number] => 11/358581 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9698 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235385.pdf [firstpage_image] =>[orig_patent_app_number] => 11358581 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/358581
Methods for enhancing expression of recombinant proteins Feb 20, 2006 Issued
11/341482 Complex for serving diabetics to reduce the concentration of blood glucose Jan 29, 2006 Abandoned
Array ( [id] => 418912 [patent_doc_number] => 07276584 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-10-02 [patent_title] => 'Isolated nucleic acid molecules encoding the Br2 P-glycoprotein of maize and methods of modifying growth in plants transformed therewith' [patent_app_type] => utility [patent_app_number] => 11/338199 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19038 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/276/07276584.pdf [firstpage_image] =>[orig_patent_app_number] => 11338199 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/338199
Isolated nucleic acid molecules encoding the Br2 P-glycoprotein of maize and methods of modifying growth in plants transformed therewith Jan 23, 2006 Issued
Array ( [id] => 5596235 [patent_doc_number] => 20060160152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Purified Stat proteins and methods of purifying thereof' [patent_app_type] => utility [patent_app_number] => 11/335005 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 28982 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160152.pdf [firstpage_image] =>[orig_patent_app_number] => 11335005 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/335005
Purified Stat proteins and methods of purifying thereof Jan 18, 2006 Issued
Array ( [id] => 5733727 [patent_doc_number] => 20060258844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Algae fluorescence protein dry powder structure and manufacturing method thereof' [patent_app_type] => utility [patent_app_number] => 11/328193 [patent_app_country] => US [patent_app_date] => 2006-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1339 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258844.pdf [firstpage_image] =>[orig_patent_app_number] => 11328193 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/328193
Algae fluorescence protein dry powder structure and manufacturing method thereof Jan 9, 2006 Abandoned
Array ( [id] => 463014 [patent_doc_number] => 07238498 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Screening methods' [patent_app_type] => utility [patent_app_number] => 11/306504 [patent_app_country] => US [patent_app_date] => 2005-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6129 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238498.pdf [firstpage_image] =>[orig_patent_app_number] => 11306504 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/306504
Screening methods Dec 29, 2005 Issued
11/315810 Method for treating obesity with zinc-charged polypeptides Dec 21, 2005 Abandoned
Array ( [id] => 668517 [patent_doc_number] => 07094758 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Apoptotic compounds' [patent_app_type] => utility [patent_app_number] => 11/294968 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14130 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094758.pdf [firstpage_image] =>[orig_patent_app_number] => 11294968 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/294968
Apoptotic compounds Dec 4, 2005 Issued
Array ( [id] => 5844930 [patent_doc_number] => 20060122376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Protein complexes having factor VIII:C activity and production thereof' [patent_app_type] => utility [patent_app_number] => 11/290051 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14884 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122376.pdf [firstpage_image] =>[orig_patent_app_number] => 11290051 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/290051
Protein complexes having factor VIII:C activity and production thereof Nov 29, 2005 Abandoned
Array ( [id] => 5716085 [patent_doc_number] => 20060079448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Compounds and methods for increasing neurogenesis' [patent_app_type] => utility [patent_app_number] => 11/288495 [patent_app_country] => US [patent_app_date] => 2005-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23943 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079448.pdf [firstpage_image] =>[orig_patent_app_number] => 11288495 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/288495
Compounds and methods for increasing neurogenesis Nov 27, 2005 Abandoned
Menu